Paradigm Biopharmaceuticals Ltd
ASX:PAR
Paradigm Biopharmaceuticals Ltd
ASX:PAR
Price:
0.285
AUD
-3.39%
Market Closed
Market Cap:
111m
AUD
P/S
Price to Sales
Price to Sales
19.5
Current
27.7
Median
7
Industry
Lower
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=19.5
Market Cap
/
111m AUD
Revenue
5.7m AUD
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
36.6
2-Years Forward
P/S
N/A
3-Years Forward
P/S
N/A
You don't have any saved screeners yet
